Madoff trustee can pursue most claims in Merkin lawsuit
NEW YORK (Reuters) – A federal judge said the trustee liquidating Bernard Madoff’s firm may pursue nearly all of his lawsuit to recoup hundreds of millions of dollars stemming from New York money manager J. Ezra Merkin’s ties to the now-imprisoned swin…
Deutsche to pay $425 million to New York regulator over Russian ‘mirror trades’
NEW YORK/FRANKFURT (Reuters) – Deutsche Bank AG has agreed to pay $425 million to New York’s banking regulator over a “mirror trading” scheme that moved $10 billion out of Russia between 2011 and 2015, the regulator said on Monday.
Japan to explain facts about its auto market to Trump: Seko
TOKYO (Reuters) – Japan will explain the facts about its auto market to U.S. President Donald Trump and seek his understanding, trade minister Hiroshige Seko said on Tuesday.
Goldman CEO takes lead on Wall Street in slamming Trump travel ban
(Reuters) – Goldman Sachs Group Inc Chief Executive Lloyd Blankfein became the first major Wall Street leader to speak out against President Donald Trump’s order to halt arrivals from several Muslim-majority countries.
Jailed Libor trader Hayes launches fresh appeal against conviction
LONDON (Reuters) – Tom Hayes, the first person worldwide to be jailed for conspiring to manipulate Libor interest rates, on Monday night launched a last-ditch appeal against his conviction and 11-year sentence in Britain, alleging his trial was unfair….
Goldman CEO takes lead on Wall Street in slamming Trump travel ban
(Reuters) – Goldman Sachs Group Inc Chief Executive Lloyd Blankfein became the first major Wall Street leader to speak out against President Donald Trump’s order to halt arrivals from several Muslim-majority countries.
Wall Street falls the most this year as Trump honeymoon sours
NEW YORK (Reuters) – Major U.S. stock indexes posted their largest drop so far in 2017 on Monday as investors worried that a curb on immigration ordered by Donald Trump was a reminder that some of the U.S. president’s policies are not market-friendly.
Sanofi, Novo Nordisk and Lilly named in patients’ price fixing suit
NEW YORK (Reuters) – Three of the biggest makers of diabetes treatments, Sanofi SA, Novo Nordisk and Eli Lilly and Co, were named in a class action lawsuit about price fixing filed by a group of patients.
Fed exempts smaller banks from part of ‘stress test’ in expected move
WASHINGTON (Reuters) – The Federal Reserve on Monday announced that smaller lenders will be exempted from parts of a rigorous “stress test” of their financial health in a move that had been expected.
U.S. inflation getting Trump lift: Wall Street strategist
NEW YORK (Reuters) – Long hibernating price inflation is taking center stage in America’s economy, in part because President Trumps’ anti-migrant policies are fueling already rising wages, a top Wall Street asset strategist said on Monday.
